IVM
InterWest Venture Management Portfolio holdings
AUM
$20.6M
This Quarter Return
+7.08%
1 Year Return
+48.5%
3 Year Return
-59.65%
5 Year Return
-75.84%
10 Year Return
–
AUM
$347M
AUM Growth
+$347M
(+187%)
Cap. Flow
+$211M
Cap. Flow
% of AUM
60.85%
Top 10 Holdings %
Top 10 Hldgs %
99.96%
Holding
12
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
PMV Pharmaceuticals
PMVP
|
$230M |
Top Sells
| 1 |
The RealReal
REAL
|
$18.8M |
Sector Composition
| 1 | Healthcare | 83.91% |
| 2 | Consumer Discretionary | 16.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
PMV Pharmaceuticals
PMVP
$74.2M
| $230M | 66.28% | +6,469,911 | New | +$230M |
|
|
2
The RealReal
REAL
$879M
| $55.8M | 16.09% | 3,854,080 -1,300,000 | -25% | -$18.8M |
|
3
Glaukos
GKOS
$5.5B
| $32M | 9.24% | 646,364 | – | – |
|
|
AGTC
4
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $7.08M | 2.04% | 1,455,904 | – | – |
|
|
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $6.23M | 1.8% | 764,918 | – | – |
|
6
Neuronetics
STIM
$220M
| $5.01M | 1.45% | 1,030,689 | – | – |
|
7
KalVista Pharmaceuticals
KALV
$678M
| $4.9M | 1.41% | 388,766 | – | – |
|
8
Cidara Therapeutics
CDTX
$1.66B
| $3.87M | 1.12% | 1,356,813 | – | – |
|
9
Venus Concept
VERO
$4.11M
| $1.53M | 0.44% | 658,657 | – | – |
|
|
HIND
10
Vyome Holdings, Inc. Common Stock
HIND
$243M
| $346K | 0.1% | 380,224 | – | – |
|
11
Xenon Pharmaceuticals
XENE
$2.98B
| $92K | 0.03% | 8,293 | – | – |
|
12
Dare Bioscience
DARE
$27.2M
| $50K | 0.01% | 50,368 | – | – |
|